A retrospective cohort study examined the association between maternal anemia before delivery and the risk of peripartum blood transfusion and other adverse perinatal outcomes; the study included 18,357 patients who delivered live, nonanomalous neonates at ≥23 weeks’ gestation, excluding those with sickle cell disease or on anticoagulation therapy.
